Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets

Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets

Abstract Giant cell arteritis (GCA) is the most common idiopathic systemic vasculitis in persons aged 50 years or greater. Treatment options for GCA, to-date, have been limited and have consisted primarily of glucocorticoids. Significant advances in the understanding of the genetic and cellular mech...

Full description

Bibliographic Details
Main Authors: Matthew J. Koster, Kenneth J. Warrington
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Rheumatology
Subjects:
Vasculitis
Giant cell arteritis
Pathogenesis
Therapeutics
Biologics
Online Access:http://link.springer.com/article/10.1186/s41927-017-0004-5

Internet

http://link.springer.com/article/10.1186/s41927-017-0004-5

Similar Items